Endocrine Research
HGH Frag 176-191 Research Peptide
HGH Frag 176-191 is presented as a endocrine research material for in vitro laboratory reference workflows. This page summarizes catalog details, available research sizes, and batch documentation status without human or veterinary use guidance.
Research Use Only - Not for human or animal consumption.
Research Focus
Synthetic fragment of the human growth hormone C-terminus (residues 176–191). Studied in preclinical research for lipolytic pathway activity independent of IGF-1 signaling. Lyophilized.
Catalog Details
- Category
- Endocrine
- Research sizes
- 1mg, 2mg, 5mg
- COA batch
- END-2490 (example/demo record)
- Purity
- 99.6%
- Updated
- May 2026
COA Documentation
Certificate-of-analysis information is provided for laboratory reference where available. Contact the research support team for current lot-specific documentation before relying on a batch record.
Review COA lookupLaboratory Handling
Review product-specific records, keep labels and lot numbers attached to internal logs, and follow qualified laboratory storage procedures for lyophilized research materials.
Related Research Products
CJC-1295 (No DAC)
CJC-1295 without drug affinity complex (DAC) is a synthetic 30-amino-acid analog of growth hormone releasing hormone. Studied in preclinical endocrine research for its activity at the GHRH receptor. Lyophilized.
CJC-1295 with DAC
CJC-1295 with drug affinity complex (DAC) is a modified GHRH analog with extended half-life through albumin binding. Studied in preclinical endocrine research. Lyophilized.
Ipamorelin
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2). Studied in preclinical endocrine research for its selective activity at the GHS-R1a (ghrelin) receptor. Lyophilized.
Tesamorelin
Tesamorelin is a synthetic analog of growth hormone releasing hormone with a hexenoyl group modification at the N-terminus for enhanced stability. Studied in preclinical endocrine research for its activity at the GHRH receptor. Lyophilized.